42543-889-04 : NDC 2026 Code

42543-889-04 : Efavirenz ( Efavirenz )

Additionally :

You can get information about “42543-889-04” NDC code in 42543-889-04 in HTML format

HTML | 42543-889-04 in TXT (Plain Text) format

TXT | 42543-889-04 in PDF (Portable Document Format)

PDF | 42543-889-04 in XML format

XML formats.

NDC Code : 42543-889-04 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42543-889-04",
    "PackageDescription": "30 TABLET in 1 BOTTLE (42543-889-04) ",
    "NDC11Code": "42543-0889-04",
    "ProductNDC": "42543-889",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Efavirenz",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Efavirenz",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210111",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA204869",
    "LabelerName": "Strides Pharma Inc.",
    "SubstanceName": "EFAVIRENZ",
    "StrengthNumber": "600",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-04-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20210111",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}